89 related articles for article (PubMed ID: 35294590)
1. Mechanism of
Deng JW; Li CY; Huang YP; Liu WF; Zhang Q; Long J; Wu WQ; Huang LH; Zeng GH; Sun XY
J Agric Food Chem; 2024 Mar; 72(12):6372-6388. PubMed ID: 38471112
[TBL] [Abstract][Full Text] [Related]
2. STUB1 exacerbates calcium oxalate-induced kidney injury by modulating reactive oxygen species-mediated cellular autophagy via regulating CFTR ubiquitination.
Hou Y; Huang C; Huang Z; Huang J; Zhu B
Urolithiasis; 2024 Apr; 52(1):55. PubMed ID: 38564006
[TBL] [Abstract][Full Text] [Related]
3. Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen species (ROS) signaling.
Kumar P; Laurence E; Crossman DK; Assimos DG; Murphy MP; Mitchell T
Redox Biol; 2023 Nov; 67():102919. PubMed ID: 37806112
[TBL] [Abstract][Full Text] [Related]
4. Carboxylated Pocoa polysaccharides inhibited oxidative damage and inflammation of HK-2 cells induced by calcium oxalate nanoparticles.
Xiong P; Zheng YY; Ouyang JM
Biomed Pharmacother; 2023 Dec; 169():115865. PubMed ID: 37972469
[TBL] [Abstract][Full Text] [Related]
5. Carboxymethylated Rhizoma alismatis polysaccharides reduces the risk of calcium oxalate stone formation by reducing cellular inflammation and oxidative stress.
Wang Z; Liu L; Li CY; Zhao YW; Tong XY; Cheng XY; Ouyang JM
Urolithiasis; 2024 Apr; 52(1):63. PubMed ID: 38613670
[TBL] [Abstract][Full Text] [Related]
6. IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury.
Chen W; Shen Y; Fan J; Zeng X; Zhang X; Luan J; Wang Y; Zhang J; Fang S; Mei X; Zhao Z; Ju D
Clin Transl Med; 2021 Feb; 11(2):e324. PubMed ID: 33634980
[TBL] [Abstract][Full Text] [Related]
7. Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury.
Bao D; Wang Y; Zhao MH
Kidney Dis (Basel); 2023 Dec; 9(6):459-468. PubMed ID: 38089442
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C-induced oxalate nephropathy: a case report.
Gurm H; Sheta MA; Nivera N; Tunkel A
J Community Hosp Intern Med Perspect; 2012; 2(2):. PubMed ID: 23882371
[TBL] [Abstract][Full Text] [Related]
9. Two instances of secondary oxalate nephropathy with concomitant acute kidney injury.
Sui D; Li X; Ji X; Feng X
Asian J Surg; 2024 Jun; ():. PubMed ID: 38910087
[No Abstract] [Full Text] [Related]
10. Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article.
Stepanova N
Front Pharmacol; 2021; 12():692429. PubMed ID: 34122117
[No Abstract] [Full Text] [Related]
11. Cell death‑related molecules and targets in the progression of urolithiasis (Review).
Wu L; Xue X; He C; Lai Y; Tong L
Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38666544
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis reveals calcium-sensing receptor gene regulating cell-cell junction in renal tubular epithelial cells.
Zhou Z; Gao P; Zhang T; Yang Y; Ding Q; Wu Z; Wang L
Int Urol Nephrol; 2024 Jul; 56(7):2165-2177. PubMed ID: 38372840
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response.
Gu Y; Shen Y; Chen W; He H; Ma Y; Mei X; Ju D; Liu H
Appl Microbiol Biotechnol; 2022 Apr; 106(7):2637-2649. PubMed ID: 35294590
[TBL] [Abstract][Full Text] [Related]
14. Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway.
Liu J; Huang J; Gong B; Cheng S; Liu Y; Chen Y; Feng Q; Li J; Qiu M; Yu G; Liao Y
Biomed Pharmacother; 2023 Nov; 167():115621. PubMed ID: 37793278
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses.
Shen Y; Jin X; Chen W; Gao C; Bian Q; Fan J; Luan J; Cao Z; Guo Z; Gu Y; Liu H; Ju D; Mei X
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5889-5898. PubMed ID: 32356198
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome.
Sun Y; Liu Y; Guan X; Kang J; Wang X; Liu Q; Li D; Xu H; Tao Z; Deng Y
IUBMB Life; 2020 May; 72(5):1065-1074. PubMed ID: 32083808
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.
Khan SR
J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011
[TBL] [Abstract][Full Text] [Related]
18. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
